DreamCIS, Inc. Share Price

Equities

A223250

KR7223250002

Healthcare Facilities & Services

End-of-day quote Korea S.E. 03:30:00 30/04/2024 am IST 5-day change 1st Jan Change
3,010 KRW +1.52% Intraday chart for DreamCIS, Inc. +10.26% -7.53%

Financials

Sales 2022 38.87B 28.26M 2.36B Sales 2023 47.84B 34.78M 2.9B Capitalization 75.04B 54.56M 4.55B
Net income 2022 4.4B 3.2M 267M Net income 2023 3.74B 2.72M 227M EV / Sales 2022 1.13 x
Net cash position 2022 17.56B 12.77M 1.06B Net cash position 2023 16.79B 12.2M 1.02B EV / Sales 2023 1.22 x
P/E ratio 2022
13.8 x
P/E ratio 2023
20.7 x
Employees 236
Yield 2022 *
-
Yield 2023
-
Free-Float 28.16%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.52%
1 week+10.26%
Current month+0.84%
1 month+0.84%
3 months-0.66%
6 months-12.75%
Current year-7.53%
More quotes
1 week
2 720.00
Extreme 2720
3 175.00
1 month
2 610.00
Extreme 2610
3 175.00
Current year
2 610.00
Extreme 2610
3 475.00
1 year
2 610.00
Extreme 2610
9 750.00
3 years
2 370.00
Extreme 2370
9 750.00
5 years
2 370.00
Extreme 2370
9 750.00
10 years
2 370.00
Extreme 2370
9 750.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 -
Director of Finance/CFO 55 -
Members of the board TitleAgeSince
Chief Executive Officer 56 -
Director/Board Member 43 -
Director of Finance/CFO 55 -
More insiders
Date Price Change Volume
30/24/30 3,010 +1.52% 577,794
29/24/29 2,965 -.--% 107,587
26/24/26 2,965 +0.68% 276,549
25/24/25 2,945 +6.13% 1,467,301
24/24/24 2,775 +2.40% 116,911

End-of-day quote Korea S.E., April 30, 2024

More quotes
DreamCIS Inc is a Korea-based company principally engaged in the business of contract clinical trial. The Company mainly provides services include regulatory post-marketing surveillance (rPMS), clinical trial, non-interventional study (NIS) and others. The Company provides its services within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A223250 Stock